MCID: MYC005
MIFTS: 44

Myocardial Stunning malady

Category: Cardiovascular diseases

Aliases & Classifications for Myocardial Stunning

About this section

Aliases & Descriptions for Myocardial Stunning:

Name: Myocardial Stunning 11 50 39 13 68

Classifications:



External Ids:

Disease Ontology11 DOID:9767
MeSH39 D017682

Summaries for Myocardial Stunning

About this section
Wikipedia:71 In cardiology, stunned myocardium is a state when some section of the myocardium (corresponding to area... more...

MalaCards based summary: Myocardial Stunning is related to myocardial infarction and ischemia, and has symptoms including asthenia, body temperature changes and cyanosis. An important gene associated with Myocardial Stunning is SLC9A1 (Solute Carrier Family 9 Member A1), and among its related pathways are Cardiac muscle contraction and Doxorubicin Pathway, Pharmacokinetics. Affiliated tissues include heart, neutrophil and skin, and related mouse phenotypes are Negative genetic interaction between BLM-/- and BLM+/+ and cardiovascular system.

Related Diseases for Myocardial Stunning

About this section

Diseases related to Myocardial Stunning via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 51)
idRelated DiseaseScoreTop Affiliating Genes
1myocardial infarction29.9AGTR1, EDN1, SERPINC1, TNNI3, TNNT2
2ischemia10.4
3cardiomyopathy10.3
4isolated brachycephaly10.2TNNI3, TNNT2
5glomerulonephritis10.2TNNI3, TNNT2
6central cord syndrome10.2KCNJ5, SOD1
7eosinophilic pneumonia10.1AGTR1, TNNI3
8mental retardation hypocupremia hypobetalipoproteinemia10.1AGTR1, SOD1
9neurological manifestations of pompe disease10.1CAT, SOD1
10mosaic trisomy 110.1TNNI3, TNNT2
11retinitis pigmentosa 1810.1TNNI3, TNNT2
12stickler sydrome, type i, nonsyndromic ocular10.1CAT, SOD1
13lupus erythematosus10.1SERPINC1, TNNI3, TNNT2
14sialadenitis10.1AGTR1, EDN1
15eastern equine encephalitis10.1AGTR1, EDN1
16leukocyte disease10.1SERPINC1, TNNI3, TNNT2
17intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies10.1AGTR1, KCNJ5
18aplasia cutis congenita recessive10.1AGTR1, EDN1
19acute myocardial infarction10.1
20endotheliitis10.1
21sick sinus syndrome 110.1KCNJ5, SLC9A1, TNNT2
22coronary artery disease10.0
23artery disease10.0
24alpha-2-plasmin inhibitor deficiency10.0AGTR1, EDN1, SERPINC1
25welander distal myopathy10.0AGTR1, EDN1, SERPINC1
26petrositis10.0AGTR1, EDN1
27neonatal diabetes mellitus10.0CAT, EDN1
28adult t-cell leukemia9.9EDN1, SERPINC1, TNNI3, TNNT2
29ceroid lipofuscinosis, neuronal, 89.9CAT, EDN1, TNNT2
30indeterminate leprosy9.9AHSP, EDN1, TNNI3
31lymphadenitis9.9AGTR1, EDN1
32mucinous ovarian cystadenoma9.9CAT, EDN1, SLC9A1, SOD1
33pyrimidine metabolic disorder9.9AGTR1, EDN1, SERPINC1, TNNI3
34cardiac arrest9.9
35pulmonary edema9.9
36aneurysm9.9
37hypoxia9.9
38cardiogenic shock9.9
39pericarditis9.8CAT, EDN1, SERPINC1, SOD1
40xanthogranulomatous pyelonephritis9.7AGTR1, EDN1, SOD3, TNNI3, TNNT2
41pheochromocytoma9.7
42pulmonary hypertension9.7
43status epilepticus9.7
44epilepsy9.7
45cervicitis9.7
46cerebritis9.7
47coronary stenosis9.7
48kidney disease9.7
49hyperthyroidism9.7
50peritonitis9.7

Graphical network of the top 20 diseases related to Myocardial Stunning:



Diseases related to myocardial stunning

Symptoms & Phenotypes for Myocardial Stunning

About this section

UMLS symptoms related to Myocardial Stunning:


asthenia, body temperature changes, cyanosis, edema, eye manifestations, fatigue, flushing, oral manifestations, signs and symptoms, signs and symptoms, digestive, signs and symptoms, respiratory, skin manifestations, chills, polydipsia, renal colic, hot flushes, urological manifestations, mobility limitation, prodromal symptoms, hypertriglyceridemic waist, medically unexplained symptoms

GenomeRNAi Phenotypes related to Myocardial Stunning according to GeneCards Suite gene sharing:

26
idDescriptionGenomeRNAi Source AccessionScoreTop Affiliating Genes
1GR00255-A-19.1EDN1, SOD3, TNNI3, TNNT2

MGI Mouse Phenotypes related to Myocardial Stunning according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053858.2AGTR1, EDN1, KCNJ5, SERPINC1, SLC9A1, SOD1
2MP:00053767.9AGTR1, CAT, EDN1, SERPINC1, SLC9A1, SOD1
3MP:00107687.5AGTR1, CAT, EDN1, SERPINC1, SLC9A1, SOD1

Drugs & Therapeutics for Myocardial Stunning

About this section

Drugs for Myocardial Stunning (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 73)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
HydroxocobalaminapprovedPhase 425813422-51-011953898, 5460373, 44475014
Synonyms:
13422-51-0
22465-48-1
78091-12-0
8017-22-9
Acti-B12
AlphaRedisol
AlphaRedisol (TN)
Axion
Axlon
Benzimidazolyl ribofuranosyl phosphate deriv.
C08230
C62H85CoN13O15P
CHEBI:27786
CHEMBL1200742
CHEMBL235822
CID11622291
CID11953898
CID5460373
CID6433575
CID6474319
Ciplamin H
Coalpha-[alpha-(5,6-dimethylbenzimidazolyl)]-Cobeta-hydroxocobamide
Cobalex
Cobalin H
Cobinamide dihydroxide dihydrogen phosphate (ester), mono(inner salt), 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosylbenzimidazole
Cobinamide hydroxide phosphate 3'-ester with 5,6-dimethyl-1-a-D-ribofuranosylbenzimidazole inner salt
Cobinamide hydroxide phosphate 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosylbenzimidazole inner salt
Cobinamide hydroxide phosphate 3'-ester with 5,6-dimethyl-1-alpha-delta-ribofuranosylbenzimidazole inner salt
Cobinamide, Co-hydroxy-, dihydrogen phosphate (ester), inner salt, 3'-ester with (5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole-kappaN3)
Cobinamide, Co-hydroxy-, f-(dihydrogen phosphate), inner salt, 3'-ester with (5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole-kappaN3)
Cobinamide, dihydroxide, dihydrogen phosphate (ester), mono (inner salt), 3'- ester with 5,6-dimethyl-1-alpha-D-ribofuranosylbenzimidazole
Cobinamide, dihydroxide, dihydrogen phosphate (ester), mono(inner salt), 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole
Cobinamide, hydroxide, dihydrogen phosphate (ester), inner salt, 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole
Codroxomin
Cyanokit
Cyanokit (TN)
D01027
DB00200
Depogamma
Docclan
Docelan
Docelvita
Docevita
Droxomin
Ducobee Hy
Ducobee-Hy
Duradoce
Duralta-12
EINECS 236-533-2
HSDB 3342
HYDROXOCOBALAMIN
Hidroxocobalamina
Hidroxocobalamina [INN-Spanish]
Hydro Cobex
 
Hydrobamine
Hydrocobalamin
Hydrogrisevit
Hydrovit
Hydroxocobalamin
Hydroxocobalamin (JAN/USP/INN)
Hydroxocobalamin Vitamin B12
Hydroxocobalamin [USAN:INN:BAN:JAN]
Hydroxocobalamin acetate
Hydroxocobalamin anhydrous
Hydroxocobalamin monohydrochloride
Hydroxocobalamin(alkaline soln.), OH- replaces CN- in Cyanocobalamin)
Hydroxocobalaminacetat
Hydroxocobalamine
Hydroxocobalamine [INN-French]
Hydroxocobalaminum
Hydroxocobalaminum [INN-Latin]
Hydroxocobalaminum anhydrous
Hydroxocobemine
Hydroxomin
Hydroxy Cobal
Hydroxy vitamin B12
Hydroxycob(lll)alamin
Hydroxycobalamin
Hydroxycobalamine
Hyxobamine
Idrogrisevit
Idrossocobalamina
Idrossocobalamina [DCIT]
LS-54607
Lyovit-H
Neo-Betalin 12
Neo-cytamen
Neo-macrabin
Neo-rojamin
OH-Cbl
OH-Duphar
Ohb12
Oxobemin
Oxolamine (arcum)
Primabalt RP
Redisol-H
S1668_Selleck
Sytobex-H
UNII-Q40X8H422O
Vibeden
Vitadurin
Vitamin B(sub 12a)
Vitamin B-12b
Vitamin B12a
Vitamin B12b
a-(5,6-Dimethylbenzimidazolyl)hydroxocobamide
alpha Cobione
alpha-(5,6-Dimethylbenzimidazolyl)hydroxocobamide
vitamin B-12b
2
Metoprololapproved, investigationalPhase 421237350-58-6, 51384-51-14171
Synonyms:
(+/-)-Metoprolol
(RS)-Metoprolol
1-(Isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol
1-(Isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-2-propanol
1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol
1-[(1-methylethyl)amino]-3-({4-[2-(methyloxy)ethyl]phenyl}oxy)propan-2-ol
1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol
1-[4-(2-methoxyethyl)phenoxy]-3-propan-2-ylamino-propan-2-ol
3-[4-(2-methoxyethyl)phenoxy]-1-(propan-2-ylamino)propan-2-ol
37350-58-6
51384-51-1
54163-88-1
AB00053499
AC-19022
AC1L1HKM
AstraZeneca Brand of Metaoprolol Tartrate
AstraZeneca Brand of Seloken
BRD-A03623303-045-02-0
Beatrolol
Beloc
Beloc Duriles
Beloc-Duriles
BelocDuriles
Betaloc
Betaloc Astra
Betaloc-Astra
BetalocAstra
Betalok
C07202
CCRIS 4198
CGP 2175
CGP-2175
CGP2175
CHEBI:6904
CHEMBL13
CID4171
D008790
D02358
DB00264
DL-metoprolol
Dl-Metoprolol
Dutoprol
EINECS 253-483-7
EINECS 257-166-4
H 93 26
H 93-26
H 9326
 
HMS2090B15
HSDB 6531
I01-7125
I06-0125
Jsp006606
L000669
LOPRESSIDONE
LS-122450
Leiras Brand of Metoprolol Succinate or Metoprolol Tartrate
Lopresor
Lopresoretic
Lopressor
Lopressor HCT
Meijoprolol
Metohexal
Metoprolol
Metoprolol (USAN/INN)
Metoprolol Tartrate
Metoprolol [USAN:INN:BAN]
Metoprolol slow release
Metoprolol succinate
Metoprolol tartrate
Metoprololum
Metoprololum [INN-Latin]
Metroprolol
MolPort-005-938-039
NCGC00021148-02
NCGC00021148-03
NCGC00021148-04
Novartis Brand of Metprolol Tartrate
Preblok
Prelis
Presolol
Selo-Zok
Seloken
Seloken AstraZeneca Brand
Selopral
Seroken
Spesicor
Spesikor
TOPROL-XL
Tartrate, Metoprolol
Toprol
Toprol XL
Toprol-XL
UNII-GEB06NHM23
dl-Metoprolol
metoprolol
3
Aspirinapproved, vet_approvedPhase 4115250-78-22244
Synonyms:
11126-35-5
11126-37-7
1oxr
2-(Acetyloxy)benzoate
2-(Acetyloxy)benzoic acid
2-Acetoxybenzenecarboxylic acid
2-Acetoxybenzoate
2-Acetoxybenzoic acid
2-Carboxyphenyl acetate
2349-94-2
26914-13-6
50-78-2
8-hour Bayer
98201-60-6
A 5376
A.S.A
A.S.A.
A.S.A. Empirin
A.S.A. empirin
A2093_SIGMA
A3160_SIGMA
A5376_SIGMA
A6810_SIGMA
AB1003266
AC 5230
AC1L1D8U
AC1Q1LA0
ACETYLSALICYLIC ACID
AI3-02956
AIN
AKOS000118884
ASA
Acenterine
Acesal
Acetal
Acetard
Aceticyl
Acetilsalicilico
Acetilum acidulatum
Acetisal
Acetol
Acetonyl
Acetophen
Acetosal
Acetosalic acid
Acetosalin
Acetoxybenzoic acid
Acetylin
Acetylsal
Acetylsalicylate
Acetylsalicylic acid
Acetylsalicylsaeure
Acetylsalicylsaure
Acetylsalicylsäure
Acetylsalycilic acid
Acetyonyl
Acetysal
Acetysalicylic acid
Acide acetylsalicylique
Acido O-acetil-benzoico
Acido acetilsalicilico
Acidum acetylsalicylicum
Acimetten
Acisal
Acylpyrin
Adiro
Aloxiprimum
Asacard
Asagran
Asatard
Ascoden-30
Aspalon
Aspec
Aspergum
Aspir-Mox
Aspirdrops
Aspirin
Aspirin (JP15/USP)
Aspirin [BAN:JAN]
Aspirina 03
Aspirine
Asprin
Aspro
Aspro Clear
Asteric
Azetylsalizylsaeure
Azetylsalizylsäure
BIDD:GT0118
BRN 0779271
Bay-e-4465
Bayer
Bayer Aspirin 8 Hour
Bayer Buffered
Bayer Extra Strength Aspirin For Migraine Pain
Bayer Plus
Benaspir
Bi-prin
Bialpirina
Bialpirinia
Bufferin
C01405
CCRIS 3243
CHEBI:15365
CHEMBL25
CID2244
Caprin
Cardioaspirin
Cardioaspirina
Cemirit
Claradin
Clariprin
Colfarit
Contrheuma retard
Coricidin
Crystar
D00109
D001241
DB00945
Decaten
Delgesic
Dispril
DivK1c_000555
Dolean pH 8
Duramax
ECM
EINECS 200-064-1
EU-0100038
Easprin
Easprin (TN)
Ecolen
Ecotrin
Empirin
Empirin with Codeine
Endosprin
Endydol
Entericin
Enterophen
 
Enterosarein
Enterosarine
Entrophen
Extren
Globentyl
Globoid
HMS1920E13
HMS2090G03
HMS2091K13
HMS501L17
HSDB 652
Helicon
I14-7505
IDI1_000555
Idragin
Istopirin
KBio1_000555
KBio2_001725
KBio2_002271
KBio2_004293
KBio2_004839
KBio2_006861
KBio2_007407
KBio3_002149
KBio3_002751
KBioGR_000398
KBioGR_002271
KBioSS_001725
KBioSS_002272
Kapsazal
Kyselina 2-acetoxybenzoova
Kyselina acetylsalicylova
LS-143
Levius
Lopac-A-5376
Lopac0_000038
MLS001055329
MLS001066332
MLS001336045
MLS001336046
Magnecyl
Measurin
Medisyl
Micristin
MolPort-000-871-622
NCGC00015067-01
NCGC00015067-04
NCGC00015067-09
NCGC00090977-01
NCGC00090977-02
NCGC00090977-03
NCGC00090977-04
NCGC00090977-05
NCGC00090977-06
NCGC00090977-07
NCI60_002222
NINDS_000555
NSC 27223
NSC27223
NSC406186
Neuronika
Novid
Nu-seals
Nu-seals aspirin
O-(Acetyloxy)benzoate
O-(Acetyloxy)benzoic acid
O-Acetoxybenzoate
O-Acetoxybenzoic acid
O-Acetylsalicylic acid
O-Carboxyphenyl acetate
O-accetylsalicylic acid
O-acetylsalicylic acid
PL-2200
Persistin
Pharmacin
Pirseal
Polopirin
Polopiryna
Premaspin
R16CO5Y76E [UNII]
Rheumin tabletten
Rheumintabletten
Rhodine
Rhonal
Ronal
S-211
SMR000059138
SP 189
SPBio_001838
SPECTRUM1500130
ST075414
Salacetin
Salcetogen
Saletin
Salicylic acid acetate
Salicylic acid, acetate
Salospir
Solfrin
Solprin
Solprin acid
Solpyron
Solupsan
Spectrum2_001899
Spectrum3_001295
Spectrum4_000099
Spectrum5_000740
Spectrum_001245
Spira-Dine
St. Joseph
St. Joseph Aspirin for Adults
Supac
Tasprin
Temperal
Toldex
Triaminicin
Triple-sal
UNII R16CO5Y76E
UNII-R16CO5Y76E
UNII=R16CO5Y76E
UNM-0000306102
Vanquish
WLN: QVR BOV1
XAXA
Xaxa
Yasta
ZORprin
acide 2-(acétyloxy)benzoïque
acide acétylsalicylique
aspirin
cMAP_000006
component of Midol
component of Synirin
nchem.859-comp6
o-Acetoxybenzoic acid
o-Carboxyphenyl acetate
o-acetoxybenzoic acid
o-carboxyphenyl acetate
salicylic acid acetate
ácido acetilsalicílico
4
TicagrelorapprovedPhase 4316274693-27-59871419
Synonyms:
(1S,2S,3R,5S)-3-(7-((1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino)-5-(propylthio)-3H-(1,2,3)triazolo(4,5-D)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
AZD 6140
 
AZD-6140
AZD6140
Brilinta
5
Chlorhexidineapproved, vet_approvedPhase 449955-56-19552079, 2713
Synonyms:
1,1 inverted exclamation marka-Hexamethylenebis[5-(4-chlorophenyl)biguanide]
1,1'-Hexamethylene bis(5-(P-chlorophenyl)biguanide)
1,1'-Hexamethylene bis(5-(p-chlorophenyl)biguanide)
1,1'-Hexamethylenebis(5-(p-chlorophenyl)biguanide)
1,1'-Hexamethylenebis[5-(4-chlorophenyl)biguanide
1,6-Bis(5-(p-chlorophenyl)biguandino)hexane
1,6-Bis(p-chlorophenyldiguanido)hexane
1,6-Di(4'-chlorophenyldiguanido)hexane
1,6-Di(N-p-chlorophenyldiguanido)hexane
24798_FLUKA
282227_ALDRICH
348031_ALDRICH
4-12-00-01201 (Beilstein Handbook Reference)
55-56-1
AB00053427
AB1003159
AVAGARD
BPBio1_000272
BRN 2826432
BSPBio_000246
BSPBio_001977
C06902
C22H30Cl2N10
CAS-55-56-1
CCRIS 9230
CHEBI:3614
CHEMBL790
CID9552079
Chlorhexidin
Chlorhexidin [Czech]
Chlorhexidine
Chlorhexidine (INN)
Chlorhexidine Base
Chlorhexidine [INN:BAN]
Chlorhexidine gluconate
Chlorhexidinum
Chlorhexidinum [INN-Latin]
Cloresidina
Cloresidina [DCIT]
Clorhexidina
Clorhexidina [INN-Spanish]
D07668
DB00878
Decanoylacetaldehyde Sodium Sulfide
Dentisept [veterinary]
Dentisept [veterinary] (TN)
DivK1c_000761
EINECS 200-238-7
Fimeil
HMS1568M08
HSDB 7196
Hexadol
Hibiclens
Hibispray
Hibistat
I06-0621
I14-0050
IDI1_000761
 
KBio1_000761
KBio2_000717
KBio2_003285
KBio2_005853
KBio3_001197
KBioGR_000774
KBioSS_000717
LS-43917
Lisium (*Dihydrochloride*)
MK-412A
MLS001332387
MLS001332388
MLS002154209
Merfen-incolore
Merfen-incolore (TN)
MolPort-002-541-741
N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)]
N,N''''-hexane-1,6-diylbis[N'-(4-chlorophenyl)(imidodicarbonimidic diamide)]
N,N'-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradeca- nediimidamide
N,N'-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide
N,N'-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide
NCGC00016246-01
NCGC00091025-01
NCGC00091025-02
NINDS_000761
NSC526936
Nolvasan
Nolvasan (*Diacetate*)
Novalsan
Oro-Clense
Peridex
Periogard
Prestwick0_000143
Prestwick1_000143
Prestwick2_000143
Prestwick3_000143
Prestwick_53
QTL1_000020
Rotersept
SMR000857146
SPBio_000210
SPBio_002185
STK089248
STOCK1S-18831
Savloclens
Savlon babycare
Sebidin A
Sodium Houttuyfonamide
Soretol
Spectrum2_000135
Spectrum3_000339
Spectrum4_000277
Spectrum5_001322
Spectrum_000237
Sterido
Sterilon
Superspray
Tubulicid
UNII-R4KO0DY52L
chlorhexidine
6
Ranolazineapproved, investigationalPhase 480142387-99-3, 95635-55-556959
Synonyms:
( -)-Ranolazine
(-)-Ranolazine
142387-99-3
95635-55-5
AC-1673
AC1L1M17
AC1Q5LYD
BRD-A97674275-001-01-9
BSPBio_002276
CHEMBL1404
CID56959
CVT-303
D05700
DB00243
HMS1922F16
HMS2090L09
HMS2093D21
I01-2008
I06-0160
KEG-1295
LS-187267
Latixa
Lopac0_001062
 
MLS002154149
MolPort-003-666-653
N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide
NCGC00015897-05
NCGC00095177-01
NCGC00095177-02
NCGC00095177-03
RAN D
RANOLAZINE
RS-43285
RS-43285-003
Ran4
Ranexa
Ranexa (TN)
Ranexa, Ranolazine
Ranolazine (USAN/INN)
Ranolazine 2HCl
Ranolazine Dihydrochloride
Ranolazine dihydrochloride
S1799_Selleck
SMR000857382
SPECTRUM1505366
UNII-A6IEZ5M406
ranolazine
7
Folic Acidapproved, nutraceutical, vet_approvedPhase 4439259-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
Folsaeure
 
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
8
Cyanocobalaminapproved, nutraceuticalPhase 425968-19-944176380
Synonyms:
Anacobin
Bedoz
Berocca PN
Berubigen
Betalin 12
Betalin 12 Crystalline
Betaline-12
Betolvex
Bevidox
Bevidox concentrate
Biocobalamine
Byladoce
Cabadon m
Cernevit-12
Cobadoce forte
Cobalin
Cobavite
Cobex
Cobolin-M
Copharvit 5000
Covit
Crystamin
Crystamine
Crysti-12
Crystimin
Crystwel
Cyano-B12
Cyanobalamin concentrate
Cyanocob(III)alamin
Cyanocobalamin (JP15/USP)
Cyanocobalamin Co 57 Schilling Test Kit
Cyanocobalamine
Cyanocobalmin
Cyanoject
Cycobemin
Cycolamin
Cykobemin
Cykobeminet
Cyomin
Cyredin
Cytacon
Cytamen
Cytobion
Depinar
Dicopac
Dicopac Kit
Dimethylbenzimidazoylcobamide
Distivit
Docemine
Docibin
Docivit
Dodecabee
Dodecavite
Dodex
Duodecibin
Embiol
Emociclina
Eritrone
Erycytol
 
Erythrotin
Euhaemon
Extrinsic factor
Factor II
Fermin
Fresmin
Hemomin
Hepagon
Hepavis
Hepcovite
Hylugel plus
Infuvite Pediatric
Lactobacillus lactis dorner factor
M.V.I. Pediatric
Macrabin
Megabion
Megalovel
Milbedoce
Millevit
Nagravon
Nascobal
Nascobal (TN)
Neuroforte-R
Normocytin
Novidroxin
Pernaemon
Pernaevit
Pernipuron
Plecyamin
Poyamin
Primabalt
Rebramin
Redamina
Redisol
Rhodacryst
Rubesol
Rubivite
Rubramin
Rubramin PC
Rubratope-57 Kit
Rubratope-60 Kit
Rubripca
Rubrocitol
Ruvite
Shovite
Sytobex
Vi-Twel
Vibal
Vibalt
Vibisone
Virubra
Vita-rubra
Vitabee 12
Vitamin B12
Vitamin B12 Preparation
Vitamin B12 complex
Vitaped
Vitarubin
Vitral
vitamine b12
9
Clopidogrelapproved, nutraceuticalPhase 4778120202-66-6, 113665-84-260606
Synonyms:
( )-(S)-Clopidogrel
(+)-(S)-Clopidogrel
(+)-Clopidogrel
(S)-Clopidogrel
(S)-Methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate
113665-84-2
AC-19024
AC1L1TKZ
AC1Q41I9
BIDD:GT0284
BRD-K27721098-065-02-9
BSPBio_003211
C16H16ClNO2S
CGE
CHEBI:37941
CHEMBL1771
CID60606
CLOPIDOGREL SULFATE
CPD000550475
Clopidogrel
Clopidogrel (INN)
Clopidogrel (TN)
Clopidogrel [BAN:INN]
Clopidogrel [Ban:Inn]
Clopidogrel [INN:BAN]
Clopidogrel bisulfate
Clopidogrel bisulphate
Clopidogrel sulfate
Clopidogrelum
D07729
DB00758
DivK1c_000787
HMS2090O21
HMS502H09
HSDB 7430
IDI1_000787
 
Isocover
KBio1_000787
KBio2_000545
KBio2_003113
KBio2_005681
KBio3_002431
KBioGR_000689
KBioSS_000545
LS-172232
MLS001165708
MLS001195633
MLS001304711
Methyl (+)-(S)-alpha-(o-chlorophenyl)-6,7-dihydrothieno(3,2-c)pyridine-5(4H)-acetate
MolPort-002-885-817
MolPort-003-845-991
NCGC00163329-02
NINDS_000787
Plavix
Plavix (TN)
SAM002589956
SMR000550475
SPBio_000463
SR 25990
STK580572
STOCK5S-27782
Spectrum2_000512
Spectrum3_001606
Spectrum4_000175
Spectrum_000105
TL8000400
UNII-A74586SNO7
Zyllt
clopidogrel
clopidogrel, (+)(S)-isomer
methyl (2S)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)ethanoate
methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate
nchem.651-comp8
10Vitamin B 12Phase 4259
11Anti-Arrhythmia AgentsPhase 4, Phase 23093
12VitaminsPhase 45282
13Vasodilator AgentsPhase 4, Phase 23543
14Vitamin B ComplexPhase 44337
15Protective AgentsPhase 4, Phase 27443
16MicronutrientsPhase 46001
17HematinicsPhase 41684
18Cardioplegic SolutionsPhase 413
19Trace ElementsPhase 46001
20Pharmaceutical SolutionsPhase 48192
21SimendanPhase 4, Phase 255
22Phosphodiesterase InhibitorsPhase 4, Phase 21289
23Peripheral Nervous System AgentsPhase 423689
24Calcium, DietaryPhase 45713
25Neurotransmitter AgentsPhase 418340
26Autonomic AgentsPhase 410150
27Adrenergic AgentsPhase 45352
28Hydroxymethylglutaryl-CoA Reductase InhibitorsPhase 41998
29Fibrinolytic AgentsPhase 42388
30Cyclooxygenase InhibitorsPhase 42870
31Hypolipidemic AgentsPhase 42785
32SympatholyticsPhase 4580
33Lipid Regulating AgentsPhase 42766
34Purinergic P2Y Receptor AntagonistsPhase 4793
35Rosuvastatin CalciumPhase 4476147098-20-2
36Purinergic P2 Receptor AntagonistsPhase 4795
37Platelet Aggregation InhibitorsPhase 42516
38Analgesics, Non-NarcoticPhase 46501
39Adrenergic AntagonistsPhase 41573
40Chlorhexidine gluconatePhase 4499
41Anticholesteremic AgentsPhase 42025
42Adrenergic beta-1 Receptor AntagonistsPhase 4364
43AntimetabolitesPhase 412054
44Antihypertensive AgentsPhase 44207
45Anti-Inflammatory AgentsPhase 410729
46AntipyreticsPhase 41605
47Antirheumatic AgentsPhase 410956
48calcium channel blockersPhase 41985
49Adrenergic beta-AntagonistsPhase 41193
50Atorvastatin CalciumPhase 4760134523-03-8

Interventional clinical trials:

(show all 16)
idNameStatusNCT IDPhase
1Intracoronary Administration of Levosimendan in Cardiac Surgery PatientsUnknown statusNCT01500785Phase 4
2The Success of Opening Single CTO Lesions to Improve Myocardial Viability Study (SOS-comedy)Enrolling by invitationNCT02767401Phase 4
3Ranolazine a Potential New Therapeutic ApplicationNot yet recruitingNCT02687269Phase 4
4Adjunctive Mild Hypothermia Therapy to Primary Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction Complicated With Shock: A Feasibility StudyUnknown statusNCT00846222Phase 3
5Levosimendan Administration in Neonates With Transposition of the Great ArteriesCompletedNCT01120106Phase 2
6Serial Echocardiography After Subarachnoid HemorrhageUnknown statusNCT00123695
7Myocardial Stunning During Hemodialysis: Role of Dialyste Calcium ConcentrationCompletedNCT02545426
8Cardiac Sympathetic Activity in Patients With the Apical Ballooning SyndromeCompletedNCT00586183
9Evaluation of Myocardial Viability by Means of Low-dose Dobutamine Gated SPECT (the DOGS Study)CompletedNCT00213746
10Exercise-induced Changes in Cardiac Function & MorphologyCompletedNCT01179802
11Analysis of Heart Muscle Function Following Exercise in Patients With Heart DiseaseCompletedNCT00001528
12Trial of Dialysate Sodium in Chronic Hospitalized Hemodialysis PatientsRecruitingNCT02145260
13Clinical Study of Liraglutide in Improving Cardiac Function for Patients With Ischemic CardiomyopathyEnrolling by invitationNCT02930265
14Rate of Left Ventricular Systolic Function's Recuperation After Cardiac Surgery With Extracorporeal Circulation.Not yet recruitingNCT02770183
15Risk Assessment by Cardiovascular Biomarkers in Chronic Dialysis PatientsNot yet recruitingNCT02207153
16Steroid-induced Reduction of Surgical Stress StudyWithdrawnNCT00807521

Search NIH Clinical Center for Myocardial Stunning


Cochrane evidence based reviews: myocardial stunning

Genetic Tests for Myocardial Stunning

About this section

Anatomical Context for Myocardial Stunning

About this section

MalaCards organs/tissues related to Myocardial Stunning:

36
Heart, Neutrophil, Skin, Eye, Endothelial, Testes, Kidney

Publications for Myocardial Stunning

About this section

Articles related to Myocardial Stunning:

(show top 50)    (show all 422)
idTitleAuthorsYear
1
Doppler echocardiographic myocardial stunning index predicts recovery of left ventricular systolic function after primary percutaneous coronary intervention. (27543440)
2016
2
Pentobarbital-Induced Myocardial Stunning in Status Epilepticus Requiring Extracorporeal Membrane Oxygenation: A Case Report and Literature Review. (27529037)
2016
3
Parafascicular nucleus-heart neural crosstalk: Implications for seizure-induced myocardial stunning. (27539366)
2016
4
Citric Acid Cycle Metabolites Predict the Severity of Myocardial Stunning and Mortality in Newborn Pigs. (27741040)
2016
5
Hemodialysis-Induced Myocardial Stunning: A Review. (26290919)
2015
6
Murine Isolated Heart Model of Myocardial Stunning Associated with Cardioplegic Arrest. (26275089)
2015
7
CASE 0-2015 Problem-Solving in Transcatheter Aortic Valve Replacement: Cardiovascular Collapse, Myocardial Stunning, and Mitral Regurgitation. (26119409)
2015
8
Reply to the letter "Post-ischemic myocardial stunning was the starting point of takotsubo syndrome: Restitution is justified after falling down on". (26285184)
2015
9
Prevention of myocardial stunning during percutaneous coronary interventions: novel insights from pre-treatment with glucagon-like peptide-1. (25700753)
2015
10
Acute intraoperative neurogenic myocardial stunning during intracranial endoscopic fenestration and shunt revision in a pediatric patient. (26314948)
2015
11
Ivabradine reduces myocardial stunning in patients with exercise-inducible ischaemia. (26419678)
2015
12
Post-ischemic myocardial stunning was the starting point of takotsubo syndrome: Restitution is justified after falling down on. (26163910)
2015
13
Isolated Pulmonary Edema without Myocardial Stunning in Brainstem Strokes. (26322335)
2014
14
Seizure-Induced Myocardial Stunning: A Possible Cardiac Link to Sudden Unexpected Death In Epilepsy (SUDEP). (25305671)
2014
15
Rare giant T-wave inversions associated with myocardial stunning: report of 2 cases. (25068953)
2014
16
Myocardial stunning after resuscitation from cardiac arrest following spinal anaesthesia. (24963188)
2014
17
Clinical characteristics of myocardial stunning in acute stroke. (25022725)
2014
18
Reversible T-Wave Inversions and Neurogenic Myocardial Stunning in a Patient with Recurrent Stress-Induced Cardiomyopathy. (24147830)
2013
19
Cardiomyocyte-specific overexpression of an active form of Rac predisposes the heart to increased myocardial stunning and ischemia-reperfusion injury. (23161879)
2013
20
High-dose erythropoietin during cardiac resuscitation lessens postresuscitation myocardial stunning in swine. (23806450)
2013
21
Takotsubo and Takotsubo-like syndrome: a common neurogenic myocardial stunning pathway? (23058349)
2013
22
Myocardial bridging, apical ballooning syndrome and myocardial stunning: shall we connect the dots? (23647592)
2013
23
Milrinone and levosimendan administered after reperfusion improve myocardial stunning in swine. (22994851)
2013
24
N-terminal Pro-B-type natriuretic peptide and its correlation to haemodialysis-induced myocardial stunning. (23880872)
2013
25
CMR imaging for the evaluation of myocardial stunning after acute myocardial infarction: a meta-analysis of prospective trials. (23575990)
2013
26
Spontaneous coronary artery dissection triggered post-ischemic myocardial stunning and takotsubo syndrome: two different names for the same condition. (23273747)
2013
27
Hot shot induction and reperfusion with a specific blocker of the es-ENT1 nucleoside transporter before and after hypothermic cardioplegia abolishes myocardial stunning in acutely ischemic hearts despite metabolic derangement: hot shot drug delivery before hypothermic cardioplegia. (23422047)
2013
28
Pathophysiology and pathogenesis of post-resuscitation myocardial stunning. (21584712)
2012
29
Postischemic myocardial stunning is superior to transient ischemic dilation for detecting multivessel coronary artery disease. (22185710)
2012
30
Nitric oxide has no obligatory role in isoflurane late preconditioning against myocardial stunning. (23044225)
2012
31
Troponin T for the detection of dialysis-induced myocardial stunning in hemodialysis patients. (22822013)
2012
32
Comparative assessment of rest and post-stress left ventricular volumes and left ventricular ejection fraction on gated myocardial perfusion imaging (MPI) and echocardiography in patients with transient ischaemic dilation on adenosine MPI: myocardial stunning or subendocardial hypoperfusion? (22565241)
2012
33
Isoflurane late preconditioning against myocardial stunning is associated with enhanced antioxidant defenses. (22103751)
2012
34
Huge negative T waves reaching a depth of 36 mm below the isoelectric line on ECG associated with myocardial stunning. (22126257)
2012
35
Non-invasive ventilation for severe TRALI and myocardial stunning: report and literature review. (22869453)
2012
36
Myocardial Stunning with Hemodialysis: Clinical Challenges of the Cardiorenal Patient. (22851961)
2012
37
Inhalation of hydrogen gas protects against myocardial stunning and infarction in swine. (22263852)
2012
38
Stress cardiomyopathy: a syndrome of catecholamine-mediated myocardial stunning? (22297544)
2012
39
Distinct effects of acute pretreatment with lipophilic and hydrophilic statins on myocardial stunning, arrhythmias and lethal injury in the rat heart subjected to ischemia/reperfusion. (22106818)
2011
40
Frequent hemodialysis schedules are associated with reduced levels of dialysis-induced cardiac injury (myocardial stunning). (21597028)
2011
41
Dialysis-induced myocardial stunning: the other side of the cardiorenal syndrome. (21546884)
2011
42
Individualised dialysate temperature improves intradialytic haemodynamics and abrogates haemodialysis-induced myocardial stunning, without compromising tolerability. (21346338)
2011
43
Peritoneal dialysis is not associated with myocardial stunning. (20522673)
2011
44
Complex I syndrome in myocardial stunning and the effect of adenosine. (21723387)
2011
45
Early detection of myocardial stunning using low-dose dobutamine magnetic resonance imaging. (21402349)
2011
46
Reversible myocardial stunning due to carbon monoxide exposure. (21556453)
2011
47
Investigation of myocardial stunning after cardiopulmonary resuscitation in pigs. (21565687)
2011
48
Contractile reserve and extent of transmural necrosis in the setting of myocardial stunning: comparison at cardiac MR imaging. (20392984)
2010
49
Head to head comparison of quantitative versus visual analysis of contrast CMR in the setting of myocardial stunning after STEMI: implications on late systolic function and patient outcome. (20174969)
2010
50
Coronary microcirculation changes during myocardial stunning in dogs. (20924181)
2010

Variations for Myocardial Stunning

About this section

Expression for genes affiliated with Myocardial Stunning

About this section
Search GEO for disease gene expression data for Myocardial Stunning.

Pathways for genes affiliated with Myocardial Stunning

About this section

GO Terms for genes affiliated with Myocardial Stunning

About this section

Cellular components related to Myocardial Stunning according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cardiac myofibrilGO:009751210.4TNNI3, TNNT2
2cardiac Troponin complexGO:199058410.4TNNI3, TNNT2
3myofibrilGO:003001610.3TNNI3, TNNT2
4T-tubuleGO:00303159.9KCNJ5, SLC9A1
5troponin complexGO:00058619.9TNNI3, TNNT2

Biological processes related to Myocardial Stunning according to GeneCards Suite gene sharing:

(show all 25)
idNameGO IDScoreTop Affiliating Genes
1regulation of cardiac muscle contraction by calcium ion signalingGO:001088210.6SLC9A1, TNNI3
2cardiac muscle contractionGO:006004810.6TNNI3, TNNT2
3muscle filament slidingGO:003004910.6TNNI3, TNNT2
4negative regulation of ATPase activityGO:003278010.6TNNI3, TNNT2
5regulation of muscle contractionGO:000693710.5TNNI3, TNNT2
6positive regulation of cardiac muscle hypertrophyGO:001061310.5EDN1, SLC9A1
7regulation of pHGO:000688510.5EDN1, SLC9A1
8regulation of sensory perception of painGO:005193010.5EDN1, SLC9A1
9response to muscle stretchGO:003599410.4EDN1, SLC9A1
10heart contractionGO:006004710.4SOD1, TNNI3
11positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathwayGO:005148210.3AGTR1, EDN1
12regulation of vasoconstrictionGO:001922910.3AGTR1, EDN1
13removal of superoxide radicalsGO:001943010.3SOD1, SOD3
14response to copper ionGO:004668810.3SOD1, SOD3
15response to activityGO:001482310.2CAT, EDN1
16superoxide anion generationGO:004255410.1EDN1, SOD1
17response to ozoneGO:001019310.0CAT, EDN1
18superoxide metabolic processGO:000680110.0SOD1, SOD3
19response to reactive oxygen speciesGO:00003029.9CAT, SOD1
20ventricular cardiac muscle tissue morphogenesisGO:00550109.9TNNI3, TNNT2
21hemoglobin metabolic processGO:00200279.7AHSP, CAT
22response to hypoxiaGO:00016669.7CAT, EDN1, SOD3
23cellular response to oxidative stressGO:00345999.7CAT, SOD1, SOD3
24response to oxidative stressGO:00069799.5CAT, SOD1, SOD3
25response to drugGO:00424939.4CAT, EDN1, SLC9A1, SOD1

Molecular functions related to Myocardial Stunning according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1protein phosphatase 2B bindingGO:003034610.0SLC9A1, SOD1
2troponin C bindingGO:00301729.9TNNI3, TNNT2
3superoxide dismutase activityGO:00047849.6SOD1, SOD3
4antioxidant activityGO:00162099.3CAT, SOD1, SOD3

Sources for Myocardial Stunning

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet